A9376

Adenosine 2′:3′-cyclic monophosphate sodium salt

≥93%

• Synonyme(s) : 2′,3′-cAMP sodium salt
• Formule linéaire : C₁₀H₁₁N₅O₆PNa
• Numéro CAS: 37063-35-7
• Poids moléculaire : 351.19
• Numéro CE : 253-328-3
• Numéro MDL: MFCD00005757
• Code UNSPSC : 41106305
• eCl@ss : 32160414
• ID de substance PubChem : 24891439
• Nomenclature NACRES : NA.51

Propriétés

• Source biologique: synthetic (organic)
• Niveau de qualité: 200
• Pureté: ≥93%
• Forme: powder
• Solubilité: water: 50 mg/mL, clear, colorless
• Température de stockage: −20°C
• Chaîne SMILES: [Na+].Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@H]4OP([O-])(=O)O[C@@H]34
• InChI: 1S/C10H12N5O6P.Na/c11-8-5-9(13-2-12-8)15(3-14-5)10-7-6(4(1-16)19-10)20-22(17,18)21-7;/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13);/q;+1/p-1/t4-,6-,7-,10-;/m1./s1
• Clé InChI: VSDSIACSNXHGOV-MCDZGGTQSA-M

Description

Application

Adenosine 2′:3′-cyclic monophosphate sodium salt has been used in lysis buffer for affinity purification and also in microscale thermophoresis measurements. It has also been used in electrophysiological studies of Tenebrio tubules.

Actions biochimiques/physiologiques

Adenosine 2′,3′-cyclic monophosphate (2′,3′-cAMP) is believed to serve as an extracellular source of adenosine. The release of extracellular 2′,3′-cAMP occurs in response to injury. 2′,3′-cAMP may be used to study the distribution and specificity of its degrading enzymes in the context of unique biological activities. 2′,3′-cAMP may also be used to study apoptosis induced at the level of mitochondrial permeability transition pores. 2′,3′-cAMP is converted into 2′-AMP and 3′-AMP which inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.

Attention

Caution: Do not confuse with the common adenosine 2′(3′)-monophosphate (mixed isomers).

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable